Cargando…

IGF2 prevents dopaminergic neuronal loss and decreases intracellular alpha-synuclein accumulation in Parkinson’s disease models

Parkinson’s disease (PD) is the second most common late-onset neurodegenerative disease and the predominant cause of movement problems. PD is characterized by motor control impairment by extensive loss of dopaminergic neurons in the substantia nigra pars compacta (SNpc). This selective dopaminergic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Arcos, Javiera, Grunenwald, Felipe, Sepulveda, Denisse, Jerez, Carolina, Urbina, Valentina, Huerta, Tomas, Troncoso-Escudero, Paulina, Tirado, Daniel, Perez, Angela, Diaz-Espinoza, Rodrigo, Nova, Esteban, Kubitscheck, Ulrich, Rodriguez-Gatica, Juan Eduardo, Hetz, Claudio, Toledo, Jorge, Ahumada, Pablo, Rojas-Rivera, Diego, Martín-Montañez, Elisa, Garcia-Fernandez, María, Vidal, René L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10693583/ https://www.ncbi.nlm.nih.gov/pubmed/38042807 http://dx.doi.org/10.1038/s41420-023-01734-1

Ejemplares similares

On the Right Track to Treat Movement Disorders: Promising Therapeutic Approaches for Parkinson’s and Huntington’s Disease
por: Troncoso-Escudero, Paulina, et al.
Publicado: (2020)

Contribution of Autophagy-Lysosomal Pathway in the Exosomal Secretion of Alpha-Synuclein and Its Impact in the Progression of Parkinson’s Disease
por: Sepúlveda, Denisse, et al.
Publicado: (2022)

Insulin-like growth factor 2 and autophagy gene expression alteration arise as potential biomarkers in Parkinson’s disease
por: Sepúlveda, Denisse, et al.
Publicado: (2022)

Therapeutic potential of insulin-like growth factor 2 in Huntington’s disease: controlling proteostasis to alleviate the load of misfolded protein
por: Troncoso-Escudero, Paulina, et al.
Publicado: (2021)

Small molecules to perform big roles: The search for Parkinson's and Huntington's disease therapeutics
por: Pérez-Arancibia, Rodrigo, et al.
Publicado: (2023)

ER stress sensing mechanism: Putting off the brake on UPR transducers
por: Rojas-Rivera, Diego, et al.
Publicado: (2018)

The couple of netrin-1/α-Synuclein regulates the survival of dopaminergic neurons via α-Synuclein disaggregation
por: Kang, Eun Ji, et al.
Publicado: (2023)

Nigral overexpression of alpha-synuclein in the absence of parkin enhances alpha-synuclein phosphorylation but does not modulate dopaminergic neurodegeneration
por: Van Rompuy, Anne-Sophie, et al.
Publicado: (2015)

Nitrated α–Synuclein Immunity Accelerates Degeneration of Nigral Dopaminergic Neurons
por: Benner, Eric J., et al.
Publicado: (2008)

The Role of Alpha-Synuclein in Melanin Synthesis in Melanoma and Dopaminergic Neuronal Cells
por: Pan, Tianhong, et al.
Publicado: (2012)

In silico modeling of the effects of alpha-synuclein oligomerization on dopaminergic neuronal homeostasis
por: Ouzounoglou, Eleftherios, et al.
Publicado: (2014)

Alpha-Synuclein: The Spark That Flames Dopaminergic Neurons, In Vitro and In Vivo Evidence
por: Henriques, Alexandre, et al.
Publicado: (2022)

Neuronal haemoglobin induces loss of dopaminergic neurons in mouse Substantia nigra, cognitive deficits and cleavage of endogenous α-synuclein
por: Santulli, Chiara, et al.
Publicado: (2022)

Nitrated α-Synuclein Induces the Loss of Dopaminergic Neurons in the Substantia Nigra of Rats
por: Yu, Zhongwang, et al.
Publicado: (2010)

Alpha-Synuclein Cell-to-Cell Transfer and Seeding in Grafted Dopaminergic Neurons In Vivo
por: Angot, Elodie, et al.
Publicado: (2012)

TDP-43 Potentiates Alpha-synuclein Toxicity to Dopaminergic Neurons in Transgenic Mice
por: Tian, Tian, et al.
Publicado: (2011)

Age-Dependent Effects of A53T Alpha-Synuclein on Behavior and Dopaminergic Function
por: Oaks, Adam W., et al.
Publicado: (2013)

Protective effect of alpha-synuclein knockdown on methamphetamine-induced neurotoxicity in dopaminergic neurons
por: Tai, Yunchun, et al.
Publicado: (2014)

Mitochondrial damage by α-synuclein causes cell death in human dopaminergic neurons
por: Ganjam, Goutham K., et al.
Publicado: (2019)

Impact of α‐synuclein spreading on the nigrostriatal dopaminergic pathway depends on the onset of the pathology
por: Sun, Fanfan, et al.
Publicado: (2021)

Hypoxic stress accelerates the propagation of pathological alpha‐synuclein and degeneration of dopaminergic neurons
por: Guo, Mengyuan, et al.
Publicado: (2022)

Impact of α-synuclein pathology on transplanted hESC-derived dopaminergic neurons in a humanized α-synuclein rat model of PD
por: Hoban, Deirdre B., et al.
Publicado: (2020)

β-synuclein potentiates synaptic vesicle dopamine uptake and rescues dopaminergic neurons from MPTP-induced death in the absence of other synucleins
por: Ninkina, Natalia, et al.
Publicado: (2021)

Alpha-Synuclein Disrupted Dopamine Homeostasis Leads to Dopaminergic Neuron Degeneration in Caenorhabditis elegans
por: Cao, Pengxiu, et al.
Publicado: (2010)

Aggregation of αSynuclein promotes progressive in vivo neurotoxicity in adult rat dopaminergic neurons
por: Taschenberger, Grit, et al.
Publicado: (2011)

Rasagiline protects against alpha-synuclein induced sensitivity to oxidative stress in dopaminergic cells
por: Chau, K.Y., et al.
Publicado: (2010)

Nanomolar concentration of alpha-synuclein enhances dopaminergic neuronal survival via Akt pathway
por: Kim, Ji-Young, et al.
Publicado: (2013)

No apparent transmission of transgenic α–synuclein into nigrostriatal dopaminergic neurons in multiple mouse models
por: Sastry, Namratha, et al.
Publicado: (2015)

Bimolecular Fluorescence Complementation of Alpha-synuclein Demonstrates its Oligomerization with Dopaminergic Phenotype in Mice
por: Cai, Waijiao, et al.
Publicado: (2018)

Optogenetic Rescue of Locomotor Dysfunction and Dopaminergic Degeneration Caused by Alpha-Synuclein and EKO Genes
por: Qi, Cheng, et al.
Publicado: (2017)

α-synuclein overexpression in the retina leads to vision impairment and degeneration of dopaminergic amacrine cells
por: Marrocco, Elena, et al.
Publicado: (2020)

Early-onset impairment of the ubiquitin-proteasome system in dopaminergic neurons caused by α-synuclein
por: McKinnon, Chris, et al.
Publicado: (2020)

Inhibition of HDAC6 activity protects dopaminergic neurons from alpha-synuclein toxicity
por: Francelle, Laetitia, et al.
Publicado: (2020)

Synuclein Proteins in MPTP-Induced Death of Substantia Nigra Pars Compacta Dopaminergic Neurons
por: Goloborshcheva, Valeria V., et al.
Publicado: (2022)

Unilateral intranigral administration of β-sitosterol β-D-glucoside triggers pathological α-synuclein spreading and bilateral nigrostriatal dopaminergic neurodegeneration in the rat
por: Soto-Rojas, Luis O., et al.
Publicado: (2020)

Upregulating β-hexosaminidase activity in rodents prevents α-synuclein lipid associations and protects dopaminergic neurons from α-synuclein-mediated neurotoxicity
por: Brekk, Oeystein R., et al.
Publicado: (2020)

C-terminal part of alpha-synuclein mediates its activity in promoting proliferation of dopaminergic cells
por: Yin, Juanjuan, et al.
Publicado: (2012)

Oral N-Acetyl-Cysteine Attenuates Loss of Dopaminergic Terminals in α-Synuclein Overexpressing Mice
por: Clark, Joanne, et al.
Publicado: (2010)

Minocycline inhibition of microglial rescues nigrostriatal dopaminergic neurodegeneration caused by mutant alpha-synuclein overexpression
por: Wang, Yong, et al.
Publicado: (2020)

The Convergence of Alpha-Synuclein, Mitochondrial, and Lysosomal Pathways in Vulnerability of Midbrain Dopaminergic Neurons in Parkinson’s Disease
por: Minakaki, Georgia, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_4nv0pjpuasroutmpi539ilbcua